Sialylated lewisx epitope, antibodies and diagnosis

Details Sialylated lewisx epitope, antibodies and diagnosis Sialylated lewisx epitope, antibodies and diagnosis

A - Human Necessities

61

M

167/37, 195/1.11

A61M 1/00 (2006.01) C07K 16/30 (2006.01) C07K 16/34 (2006.01)

Patent

CA 1277614

SIALYLATED LEWISx EPITOPE, ANTIBODIES AND DIAGNOSIS ABSTRACT OF THE DISCLOSURE Detection of sialylated Lewisx antigen in sera is employed as diagnostic of the presence of cancer. Conveniently, monoclonal antibodies are provided which are shown to be useful in the diagnosis of a neoplastic condition, with a wide variety of different tumors. The hybridoma CSLEX1 was deposited at the A.T.C.C. on June 20, 1984 and given Accession No. HB 8580.

484922

Affiliated with

Also associated with

Rating

Sialylated lewisx epitope, antibodies and diagnosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sialylated lewisx epitope, antibodies and diagnosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sialylated lewisx epitope, antibodies and diagnosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1333112